The results of the FIGHT and LIVE trials question the utility and safety of liraglutide in treating patients with advanced HFrEF
In the SGLT2i group, 101 participants were hospitalised (mean number of hospitalisations=2.7, median number of hospitalisations=2), with a mean and median length of stay of 2.4 and 2 days, respectively
However, several factors have been identified as significantly associated with its development
Book a consultation at our Lincoln Park clinic or via telehealth (available across Illinois)
You may also see improvements in lipid profiles and, in people with fatty liver disease, liver function tests may improve with weight loss
The tablet is relatively small, with both sides featuring a smooth surface